Global Sustained Release Excipients Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sustained Release Excipients Market Insights, Forecast to 2034
This report mainly focuses on sustained release excipients market. These medications prolong the medication's release from a tablet or capsule so that you'll get the medication's benefits over a longer period of time.
Global Sustained Release Excipients market is expected to reach to US$ 1123 million in 2024, with a positive growth of %, compared with US$ 1069 million in 2022. Backed with the increasing demand from downstream industries, Sustained Release Excipients industry is evaluated to reach US$ 1504.1 million in 2029. The CAGR will be 5.0% during 2024 to 2029.
Factors for market growth include increasing benefits over traditional dosage forms and antibiotic resistance. One of the major challenges pharmaceutical marketers face is patient compliance. When a drug needs to be taken multiple times a day, patient acceptance of the drug can be greatly reduced, with the risk of suboptimal treatment outcomes. In such cases, the standard solution to improve drug acceptance is to formulate the drug in a dosage form that releases the active ingredient stably over an extended period of time. The sustained-release profile allows for customized dosing of the active ingredient over an extended period of time, up to 24 hours. Common approaches to achieve this release rate are through the use of film coatings, ER matrices, or ER-loaded granules. This extended-release formulation has gained considerable attention in the pharmaceutical industry and is expected to continue to be an important tool in improving the patient experience with existing and new drugs.
Report Covers
This report presents an overview of global Sustained Release Excipients market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Sustained Release Excipients market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
BASF
Ashland
Roquette Freres
Colorcon
Croda Health Care
Dow
DuPont
Segment by Type
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
Pharmaceutical Companies
Biopharmaceutical Companies
Nutraceutical Manufacturers
Contract Manufacturing Organizations
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Sustained Release Excipients plant distribution, commercial date of Sustained Release Excipients, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Sustained Release Excipients introduction, etc. Sustained Release Excipients Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Sustained Release Excipients
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Sustained Release Excipients market is expected to reach to US$ 1123 million in 2024, with a positive growth of %, compared with US$ 1069 million in 2022. Backed with the increasing demand from downstream industries, Sustained Release Excipients industry is evaluated to reach US$ 1504.1 million in 2029. The CAGR will be 5.0% during 2024 to 2029.
Factors for market growth include increasing benefits over traditional dosage forms and antibiotic resistance. One of the major challenges pharmaceutical marketers face is patient compliance. When a drug needs to be taken multiple times a day, patient acceptance of the drug can be greatly reduced, with the risk of suboptimal treatment outcomes. In such cases, the standard solution to improve drug acceptance is to formulate the drug in a dosage form that releases the active ingredient stably over an extended period of time. The sustained-release profile allows for customized dosing of the active ingredient over an extended period of time, up to 24 hours. Common approaches to achieve this release rate are through the use of film coatings, ER matrices, or ER-loaded granules. This extended-release formulation has gained considerable attention in the pharmaceutical industry and is expected to continue to be an important tool in improving the patient experience with existing and new drugs.
Report Covers
This report presents an overview of global Sustained Release Excipients market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Sustained Release Excipients market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
BASF
Ashland
Roquette Freres
Colorcon
Croda Health Care
Dow
DuPont
Segment by Type
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
Segment by Application
Pharmaceutical Companies
Biopharmaceutical Companies
Nutraceutical Manufacturers
Contract Manufacturing Organizations
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Sustained Release Excipients plant distribution, commercial date of Sustained Release Excipients, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Sustained Release Excipients introduction, etc. Sustained Release Excipients Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Sustained Release Excipients
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports